Gilteritinib, a FLT3/AXL inhibitor, shows antileukemic activity in mouse models of FLT3 mutated acute myeloid leukemia
Mori, Masamichi, Kaneko, Naoki, Ueno, Yoko, Yamada, Masaki, Tanaka, Ruriko, Saito, Rika, Shimada, Itsuro, Mori, Kenichi, Kuromitsu, Sadao
Published in Investigational new drugs (01.10.2017)
Published in Investigational new drugs (01.10.2017)
Get full text
Journal Article
Broad spectrum and potent antitumor activities of YM155, a novel small‐molecule survivin suppressant, in a wide variety of human cancer cell lines and xenograft models
Nakahara, Takahito, Kita, Aya, Yamanaka, Kentaro, Mori, Masamichi, Amino, Nobuaki, Takeuchi, Masahiro, Tominaga, Fumiko, Kinoyama, Isao, Matsuhisa, Akira, Kudou, Masafumi, Sasamata, Masao
Published in Cancer science (01.03.2011)
Published in Cancer science (01.03.2011)
Get full text
Journal Article
The selective anaplastic lymphoma receptor tyrosine kinase inhibitor ASP3026 induces tumor regression and prolongs survival in non-small cell lung cancer model mice
Mori, Masamichi, Ueno, Yoko, Konagai, Satoshi, Fushiki, Hiroshi, Shimada, Itsuro, Kondoh, Yutaka, Saito, Rika, Mori, Kenichi, Shindou, Nobuaki, Soga, Takatoshi, Sakagami, Hideki, Furutani, Takashi, Doihara, Hitoshi, Kudoh, Masafumi, Kuromitsu, Sadao
Published in Molecular cancer therapeutics (01.02.2014)
Published in Molecular cancer therapeutics (01.02.2014)
Get full text
Journal Article
Synergistic Antitumor Activities of Sepantronium Bromide (YM155), a Survivin Suppressant, in Combination with Microtubule-Targeting Agents in Triple-Negative Breast Cancer Cells
Kaneko, Naoki, Yamanaka, Kentaro, Kita, Aya, Tabata, Kenji, Akabane, Takafumi, Mori, Masamichi
Published in Biological & pharmaceutical bulletin (01.12.2013)
Published in Biological & pharmaceutical bulletin (01.12.2013)
Get full text
Journal Article
Abstract 2586: ASP8273 selectively inhibits mutant EGFR signal pathway and induces tumor shrinkage in EGFR mutated tumor models
Konagai, Satoshi, Sakagami, Hideki, Yamamoto, Hiroko, Tanaka, Hiroaki, Matsuya, Takahiro, Mimasu, Shinya, Tomimoto, Yusuke, Mori, Masamichi, Koshio, Hiroyuki, Hirano, Masaaki, Kuromitsu, Sadao, Takeuchi, Masahiro
Published in Cancer research (Chicago, Ill.) (01.08.2015)
Published in Cancer research (Chicago, Ill.) (01.08.2015)
Get full text
Journal Article
Abstract B188: Preclinical antitumor activity of ASP8273, a mutant-selective irreversible EGFR inhibitor in an AXL-overexpressing NSCLC model
Kaneko, Naoki, Tanaka, Hiroaki, Konagai, Satoshi, Yamamoto, Hiroko, Sakagami, Hideki, Eguchi, Tomohiro, Matsuya, Takahiro, Mori, Masamichi, Koshio, Hiroyuki, Terasaka, Tadashi, Hirano, Masaaki, Kuromitsu, Sadao, Takeuchi, Masahiro
Published in Molecular cancer therapeutics (01.12.2015)
Published in Molecular cancer therapeutics (01.12.2015)
Get full text
Journal Article
Minodronic acid, a third-generation bisphosphonate, antagonizes purinergic P2X2/3 receptor function and exerts an analgesic effect in pain models
KAKIMOTO, Shuichiro, NAGAKURA, Yukinori, TAMURA, Seiji, WATABIKI, Tomonari, SHIBASAKI, Kumiko, TANAKA, Shohei, MORI, Masamichi, SASAMATA, Masao, OKADA, Masamichi
Published in European journal of pharmacology (01.07.2008)
Published in European journal of pharmacology (01.07.2008)
Get full text
Journal Article
Abstract 866: ASP3026, a selective ALK inhibitor, induces tumor regression in a crizotinib-refractory model and prolongs survival in an intrapleurally xenograft model
Mori, Masamichi, Kuromitsu, Sadao, Ueno, Yoko, Tanaka, Ruriko, Shimada, Itsuro, Kondoh, Yutaka, Konagai, Satoshi, Sakagami, Hideki, Fushiki, Hiroshi, Saito, Rika, Sengoku, Takanori
Published in Cancer research (Chicago, Ill.) (15.04.2012)
Published in Cancer research (Chicago, Ill.) (15.04.2012)
Get full text
Journal Article
Abstract A227: Antitumor activities of ASP3026 against EML4-ALK-dependent tumor models
Kuromitsu, Sadao, Mori, Masamichi, Shimada, Itsuo, Kondoh, Yutaka, Shindoh, Nobuaki, Soga, Takatoshi, Furutani, Takashi, Konagai, Satoshi, Sakagami, Hideki, Nakata, Mari, Ueno, Yoko, Fushiki, Hiroshi, Saito, Rika, Sasamata, Masao, Mano, Hiroyuki, Kudou, Masafumi
Published in Molecular cancer therapeutics (12.11.2011)
Published in Molecular cancer therapeutics (12.11.2011)
Get full text
Journal Article
Abstract 2821: Anti-tumor activity of ASP3026, – A novel and selective ALK inhibitor
Kuromitsu, Sadao, Mori, Masamichi, Shimada, Itsuro, Kondoh, Yutaka, Shindoh, Nobuaki, Soga, Takatoshi, Furutani, Takashi, Konagai, Satoshi, Sakagami, Hideki, Nakata, Mari, Ueno, Yoko, Saito, Rika, Sasamata, Masao, Mano, Hiroyuki, Kudou, Masafumi
Published in Cancer research (Chicago, Ill.) (15.04.2011)
Published in Cancer research (Chicago, Ill.) (15.04.2011)
Get full text
Journal Article
Sepantronium Bromide (YM155) Enhances Response of Human B-Cell Non-Hodgkin Lymphoma to Rituximab
Kita, Aya, Mitsuoka, Keisuke, Kaneko, Naoki, Nakata, Mari, Yamanaka, Kentaro, Jitsuoka, Makoto, Miyoshi, Sosuke, Noda, Akihiro, Mori, Masamichi, Nakahara, Takahito, Sasamata, Masao
Published in The Journal of pharmacology and experimental therapeutics (01.10.2012)
Published in The Journal of pharmacology and experimental therapeutics (01.10.2012)
Get full text
Journal Article
Synergistic Antitumor Activities of Sepantronium Bromide (YM155), a Survivin Suppressant, in Combination with Microtubule-Targeting Agents in Triple-Negative Breast Cancer Cells
Naoki Kaneko, Kentaro Yamanaka, Aya Kita, Kenji Tabata, Takafumi Akabane, Masamichi Mori
Published in Biological and Pharmaceutical Bulletin (01.12.2013)
Get full text
Published in Biological and Pharmaceutical Bulletin (01.12.2013)
Journal Article
Intratumoral expression of IL-7 and IL-12 using an oncolytic virus increases systemic sensitivity to immune checkpoint blockade
Nakao, Shinsuke, Arai, Yukinori, Tasaki, Mamoru, Yamashita, Midori, Murakami, Ryuji, Kawase, Tatsuya, Amino, Nobuaki, Nakatake, Motomu, Kurosaki, Hajime, Mori, Masamichi, Takeuchi, Masahiro, Nakamura, Takafumi
Published in Science translational medicine (15.01.2020)
Published in Science translational medicine (15.01.2020)
Get more information
Journal Article
Anti-tumor effect of antibody drug conjugate ASP1235 targeting Fms-like tyrosine kinase 3 with venetoclax plus azacitidine in an acute myeloid leukemia xenograft mouse model
Tsuzuki, Hirofumi, Kawase, Tatsuya, Nakazawa, Taisuke, Mori, Masamichi, Yoshida, Taku
Published in Oncotarget (20.12.2022)
Published in Oncotarget (20.12.2022)
Get full text
Journal Article
Effect of Fms-like tyrosine kinase 3 (FLT3) ligand (FL) on antitumor activity of gilteritinib, a FLT3 inhibitor, in mice xenografted with FL-overexpressing cells
Kawase, Tatsuya, Nakazawa, Taisuke, Eguchi, Tomohiro, Tsuzuki, Hirofumi, Ueno, Yoko, Amano, Yasushi, Suzuki, Tomoyuki, Mori, Masamichi, Yoshida, Taku
Published in Oncotarget (22.10.2019)
Published in Oncotarget (22.10.2019)
Get full text
Journal Article
Combination of YM155, a Survivin Suppressant, with Bendamustine and Rituximab: A New Combination Therapy to Treat Relapsed/Refractory Diffuse Large B-cell Lymphoma
KANEKO, Naoki, MITSUOKA, Keisuke, AMINO, Nobuaki, YAMANAKA, Kentaro, KITA, Aya, MORI, Masamichi, MIYOSHI, Sosuke, KUROMITSU, Sadao
Published in Clinical cancer research (01.04.2014)
Published in Clinical cancer research (01.04.2014)
Get full text
Journal Article
Non-invasive and Time-Resolved Observation of Tumors Implanted in Living Mice by Using Phase-Contrast X-ray Computed Tomography
Yoneyama, Akio, Amino, Nobuaki, Mori, Masamichi, Kudoh, Masafumi, Takeda, Tohoru, Hyodo, Kazuyuki, Hirai, Yasuharu
Published in Japanese Journal of Applied Physics (01.03.2006)
Published in Japanese Journal of Applied Physics (01.03.2006)
Get full text
Journal Article